Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	May 03, 2026	May 04, 2025
OPERATING ACTIVITIES
Net income (loss)	$ 88.0	$ (44.8)
Adjustments to reconcile to net cash used by operating activities:
Depreciation and amortization	62.6	67.7
Equity in net income of unconsolidated affiliates	(13.3)	(10.5)
Deferred taxes	(10.3)	(342.3)
Stock-based compensation expense	12.0	12.1
Impairment of goodwill and other intangible assets	0.0	479.5
Changes in operating assets and liabilities:
Trade receivables, net	92.6	21.8
Other receivables	1.7	13.6
Inventories, net	69.2	(24.3)
Accounts payable, accrued expenses and deferred revenue	(333.8)	(217.1)
Prepaid expenses	(50.4)	(42.2)
Other, net	35.2	15.1
Net cash used by operating activities	(46.5)	(71.4)
INVESTING ACTIVITIES
Purchases of property, plant and equipment	(39.5)	(26.7)
Proceeds from sale of Warner's, Olga and True&Co. women's intimates businesses	0.0	2.5
Purchases of investments held in rabbi trust	(3.7)	(4.3)
Proceeds from investments held in rabbi trust	0.9	0.5
Net cash used by investing activities	(42.3)	(28.0)
FINANCING ACTIVITIES
Net proceeds from short-term borrowings	0.0	115.0
Repayment of 2022 facilities	(3.2)	(3.0)
Net proceeds from settlement of awards under stock plans	0.0	0.1
Cash dividends	(1.8)	(1.9)
Acquisition of treasury shares	(14.9)	(572.2)
Payments of finance lease liabilities	(0.7)	(0.9)
Net cash used by financing activities	(20.6)	(462.9)
Effect of exchange rate on cash and cash equivalents	0.4	5.3
Decrease in cash and cash equivalents	(109.0)	(557.0)
Cash and cash equivalents at beginning of period	701.5	748.0
Cash and cash equivalents at end of period	$ 592.5	$ 191.0